Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery
Sponsor: University Hospital, Lille
Summary
The Physiodoloris (MetroDoloris, Lille, France) monitor, CE marqued, uses the ECG signal in order to compute the Analgesia Nociception Index (ANI) which has been shown to measure the relative parasympathetic tone, and hence to reflect the analgesia/nociception balance during general anesthesia. The primary endpoint of this randomized multicenter study is to measure whether there is a benefit to use the ANI in order to adapt remifentanil administration during propofol anesthesia for laparoscopic surgery. Primary endpoint : lesser proportion of patients presenting with at least one episode of hemodynamic reactivity, hypotension or bradycardia in the ANI guided group vs control group ?
Official title: Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery : Multicenter Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
37
Start Date
2012-06
Completion Date
2015-05
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
ANI guided remifentanil
remifentanil administration during propofol anesthesia for laparoscopic surgery is ANI guided
ANI blind arm
remifentanil administration during propofol anesthesia for laparoscopic surgery is not ANI guided
Locations (5)
University Hospital Erasme (ULB)
Brussels, Belgium
Clinique privée d'ANTONY
Antony, France
University Hospital Claude Huriez
Lille, France
University Hospital Roger Salengro
Lille, France
University Hospital
Saint-Etienne, France